Growth hormone
illegal for off-label anti-aging use
Newswise — Because of 1988
and 1990 amendments to the Food, Drug and Cosmetic Act,
off-label distribution or provision of human growth hormone
to treat aging or age-associated illnesses is illegal in the
United States, according to a report in the Journal of
the American Medical Association.
A team of three noted
health researchers revealed a largely unknown and unenforced
law that thousands of entrepreneurs and physicians are
breaking. The authors are Dr. Thomas Perls, director of the
New England Centenarian Study at Boston Medical Center and
associate professor of medicine at Boston University School
of Medicine; Dr. Neal Reisman, clinical professor of plastic
surgery at Baylor College of Medicine and associate chief of
plastic surgery at St. Luke's Episcopal Hospital, who is
also an attorney; and S. Jay Olshansky, professor of
epidemiology at the University of Illinois at Chicago School
of Public Health.
Human growth hormone, or
HGH, is a substance released by the pituitary gland that
spurs growth and development in children and adolescents. As
a drug, it can be prescribed legally only for three rare
conditions: HGH deficiency-related syndromes that cause
short stature in children, adult HGH deficiency due to rare
pituitary tumors and their treatment, and muscle-wasting
disease associated with HIV/AIDS. According to the U.S. Food
and Drug Administration, any and all other uses of the drug,
including the off-label use as an alleged treatment for
aging and its related conditions, are illegal.
But many Web sites and
anti-aging clinics market HGH with claims that the hormone
stops and reverses aging and provides many other benefits,
including improved nail and hair growth, better sleep,
improved skin tone, better digestion, increased strength,
weight loss, better eyesight and enhanced sexual function.
"Prescribing and
administering HGH has become a routine intervention in an
industry that is variably called anti-aging, regenerative,
longevity or age management medicine," said Perls. "Hundreds
of thousands of patients who have received HGH in recent
years as a purported treatment for aging are unaware that
they are receiving the drug illegally.
"Although there is no
evidence that HGH administration stops or reverses aging,
many people spend a great deal of money on these products,"
Perls said. "On the contrary, responsibly conducted and
peer-reviewed science indicates that HGH could in fact
accelerate aging and shorten lifespan. It is associated with
very high rates of serious adverse effects, and long-term
use could increase one's risk of cancer."
According to Olshansky,
"off-label use for many drugs is a normal and accepted
practice in medicine, but that is not true for growth
hormone. According to laws instituted by Congress more than
10 years ago, HGH can only be distributed for indications
specifically authorized by the Secretary of Health and Human
Services, and aging and its related disorders are not among
them. The use of HGH as an alleged anti-aging intervention
is a major public health concern not just because it is
illegal, but also because its provision for anti-aging is
not supported by science and it is potentially harmful."
Despite the fact that the
vast majority of HGH prescriptions should be for children,
74 percent of HGH prescriptions in 2004 were for people 20
and older, and 44 percent were for people 40 to 59. Sales of
HGH in 2004 totaled $622 million (almost 213,000
prescriptions) not including sales via anti-aging Web sites.
"These data suggest that a very large proportion of HGH
sales are for illegal uses," said Perls.
HGH is also distributed
through the Internet, often at a high cost and in some cases
without physician supervision, according to the researchers.
Various forms of HGH -- ranging from pills to sprays to
injectables -- are sold to consumers at a cost of $200 to
$1,000 per month. One Web site alone was estimated by the
Federal Trade Commission to have generated more than $70
million in sales of pills and sprays purported to contain
HGH or to stimulate its production.
"Millions of dollars in
profits are made off of useless pills and sprays like
these," Perls said. "Pills with HGH are destroyed in the
stomach, and because the molecule is too large to enter the
blood stream via sublingual and nasal sprays, such products
have absolutely no biological effect. You might as well be
paying hundreds of dollars for sand and water."
"In 1988 and again in
1990, the [Food, Drug and Cosmetic Act] enacted very
stringent controls with substantial penalties involving the
distribution of HGH," said Reisman.
Despite the fact that HGH
is not a Schedule III drug, like, for example, anabolic
steroids, Congress specifically authorized the Drug
Enforcement Agency to investigate offenses related to HGH
distribution.
"Hopefully our paper will
raise awareness of the legal issues surrounding the improper
distribution, marketing, and provision of HGH and discourage
this criminal practice," Reisman said.
Copies of letters to Perls
from the FDA and FDA warning letters to Web sites regarding
the illegality of HGH provision and distribution for
anti-aging can be viewed along with other documentation at
www.bumc.bu.edu/centenarian
For more information about
UIC visit
http://www.uic.edu
For more information about
the Baylor College of Medicine visit
http://www.bcm.edu